114 related articles for article (PubMed ID: 18175258)
21. Pricing and Reimbursement Conference--VisionGain's Fifth Annual Meeting.
Cleverley J
IDrugs; 2007 Jun; 10(6):373-6. PubMed ID: 17641998
[No Abstract] [Full Text] [Related]
22. 27th Annual JPMorgan Healthcare Conference--Antisoma and Keryx Biopharmaceuticals.
Croasdell G; Gale S
IDrugs; 2009 Mar; 12(3):152-4. PubMed ID: 19333892
[No Abstract] [Full Text] [Related]
23. Japanese Pharmacological Society--77th Annual Meeting. Part II. 8-10 March 2004, Osaka, Japan.
Robins P
IDrugs; 2004 Apr; 7(4):298-300. PubMed ID: 15057629
[No Abstract] [Full Text] [Related]
24. The loss of serendipity in psychopharmacology.
Klein DF
JAMA; 2008 Mar; 299(9):1063-5. PubMed ID: 18319418
[No Abstract] [Full Text] [Related]
25. Emerging trends in the management of neuropathic pain.
McCleane G
Expert Rev Neurother; 2005 Sep; 5(5):617-23. PubMed ID: 16162085
[TBL] [Abstract][Full Text] [Related]
26. American Society of Nephrology--40th Annual Conference (renal week 2007).
Wu-Wong JR
IDrugs; 2008 Jan; 11(1):30-2. PubMed ID: 18175259
[No Abstract] [Full Text] [Related]
27. 27th Annual JPMorgan Healthcare Conference--Prism and Medarex.
Croasdell G
IDrugs; 2009 Mar; 12(3):142-4. PubMed ID: 19333889
[No Abstract] [Full Text] [Related]
28. 27th Annual JPMorgan Healthcare Conference--Biogen Idec.
Gale S
IDrugs; 2009 Mar; 12(3):140-1. PubMed ID: 19333888
[No Abstract] [Full Text] [Related]
29. Interscience Conference on Antimicrobial Agents and Chemotherapy--46th annual meeting. 27-30 September 2006, San Francisco, CA, USA.
Turner B
IDrugs; 2006 Nov; 9(11):761-4. PubMed ID: 17096294
[No Abstract] [Full Text] [Related]
30. 27th Annual JPMorgan Healthcare Conference--BioCryst and Emergent Biosolutions.
Croasdell G; Gale S
IDrugs; 2009 Mar; 12(3):149-51. PubMed ID: 19333891
[No Abstract] [Full Text] [Related]
31. 27th Annual JPMorgan Healthcare Conference--Gilead and Endo Pharmaceuticals.
Gale S; Mason VL
IDrugs; 2009 Mar; 12(3):145-8. PubMed ID: 19333890
[No Abstract] [Full Text] [Related]
32. Pain therapeutics--SMi's seventh annual conference. 12-13 June 2006, London, UK.
Harrop S
IDrugs; 2006 Aug; 9(8):548-50. PubMed ID: 16871462
[No Abstract] [Full Text] [Related]
33. Interscience Conference on Antimicrobial Agents and Chemotherapy--48th Annual Meeting and Infectious Diseases Society of America-- 46th Annual Meeting Updates on therapeutic research--Part 2.
Sovran L
IDrugs; 2009 Jan; 12(1):3-4. PubMed ID: 19127493
[No Abstract] [Full Text] [Related]
34. Interscience Conference on Antimicrobial Agents and Chemotherapy--48th Annual Meeting and Infectious Diseases Society of America-- 46th Annual Meeting Updates on therapeutic research--Part 1.
Gale S
IDrugs; 2009 Jan; 12(1):1-2. PubMed ID: 19127492
[No Abstract] [Full Text] [Related]
35. Scientometrics of drug discovery efforts: pain-related molecular targets.
Kissin I
Drug Des Devel Ther; 2015; 9():3393-404. PubMed ID: 26170624
[TBL] [Abstract][Full Text] [Related]
36. Asthma & COPD - SMi's sixth annual conference.
Shah S
IDrugs; 2010 Jun; 13(6):376-8. PubMed ID: 20506058
[TBL] [Abstract][Full Text] [Related]
37. Pain therapeutics-SMi Conference. 11-12 June, 2003, London, UK.
De la Rue S
IDrugs; 2003 Jul; 6(7):652-5. PubMed ID: 12906016
[No Abstract] [Full Text] [Related]
38. Bioversity 2007.
McGee V
IDrugs; 2007 Aug; 10(8):554-6. PubMed ID: 17665330
[No Abstract] [Full Text] [Related]
39. Role of neuroimaging in analgesic drug development.
Lawrence J; Mackey SC
Drugs R D; 2008; 9(5):323-34. PubMed ID: 18721001
[TBL] [Abstract][Full Text] [Related]
40. Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.
Grösch S; Niederberger E; Geisslinger G
Expert Opin Investig Drugs; 2017 Jan; 26(1):51-61. PubMed ID: 27841017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
